PPT-Management of Atrial Fibrillation, Stroke, and Bleeding

MetaAnalysis of NOACs vs Warfarin RCT vs RealWorld Data Screening for Atrial Fibrillation to Prevent Strokes Silent AF Screening for AF Devices for LongTerm AF Screening Regular Pulse Check for Detecting AF. Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. Journal Club . October 21,2015. Kathleen McNamara, . PharmD. Stroke Risk Calculation. Which tool do you most typically use to evaluate stroke . risk for patients with a fib? . CHADS2 score. CHADS2-VASc. Mortality Risks . in . Elderly Medicare Beneficiaries . Treated . with Dabigatran . or Rivaroxaban . for . Nonvalvular. Atrial Fibrillation. To compare risks of thromboembolic stroke, intracranial hemorrhage, major . Amit Kishore. Consultant and Honorary Senior Lecturer . in Stroke Medicine , . SRFT. Amit.Kishore@srft.nhs.uk . January 2017. Cryptogenic strokes. ‘. Brain infarction . that is not attributable to a source of definite . Rhea C. Pimentel, MD. Associate Professor of Medicine. Fellowship Program Director, Clinical Cardiac Electrophysiology Program. Disclosures. Speakers Bureau: Medtronic. Speakers Bureau: St. Jude Medical. A U G U S T 2 0 1 4. Physicians. 2. Physicians. A majority of physicians believe most Atrial Fibrillation patients don’t usually understand their increased risk of stroke and feel most patients underestimate the impact ischemic stroke can have on their lives. . Mary N. Healy, MS, ARNP-BC. Heart & Vascular Center of Sarasota. OBJECTIVES. Define the difference between paroxysmal and persistent Atrial Fibrillation. State the CVA risk per year of a 68 . yr. Jennie Hsu-. Lumetta. , MD, FACP. Corinne Kohler, . MD, FAAFP. Narain. . Mandhan. , MD, FACP, FASAM. Karen . Wiarda. , . DO. Muhammad . Ajmal. , . MD, PGY 3 Chief. ACP QI . Project. Atrial Fibrillation . Overview . Definition and epidemiology. Symptoms. Tests/Evaluations. Complications. Treatment. Effects on exercise. Medications effect on exercise. Effects of training. Exercise prescription. Definition. Overview . Definition and epidemiology. Symptoms. Tests/Evaluations. Complications. Treatment. Effects on exercise. Medications effect on exercise. Effects of training. Exercise prescription. Definition. Patient back to baseline. Vitals stable. . Sent to OSH where CT head shows old stroke.. Work up at outside including cardiac echo, carotid US negative.. PMH: as above plus two previous episodes of falling. Maclennan D, Bartlett S, Cassels A, McBain I, Tompkins K, . Mcauley. S, . Cvoro. V; Ward 42, Victoria Hospital, Hayfield road, Kirkcaldy, KY2 5AH. David MacLennan. NHS Lothian/Fife. South East Scotland Deanery. Updated October 24, . 2018. Apixaban for the Reduction of Thrombo-Embolism in Device-Detected Sub-Clinical Atrial Fibrillation. Apixaban for the Reduction of Thrombo-Embolism in Device-Detected Sub-Clinical Atrial Fibrillation. ischaemic. attack in patients with. a diagnosis of resolved atrial fibrillation: . retrospective cohort. . studies.. Nicola J Adderley, . Krishnarajah. . Nirantharakumar. , Tom Marshall.. BMJ 2018.